Evidence map›Paper›PMID 40157916›Full record

ArticleNature communications2025

Synthesis of nickel(II)-containing meso-edited phthalocyanine derivatives.

Yuta Takiya, Taiga Saito, Naoyuki Toriumi, Masanobu Uchiyama

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuta TakiyaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Taiga SaitoGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Naoyuki ToriumiGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. toriumi@mol.f.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0001-5963-4735
Masanobu UchiyamaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. uchiyama@mol.f.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0001-6385-5944

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 22H00320MEXT | Japan Society for the Promotion of Science (JSPS) 24K02142MEXT | JST | Core Research for Evolutional Science and Technology (CREST) JPMJCR19R2
6 · The paper itself

Abstract

In contrast to the rich chemistry of porphyrin and its analogs, the structural variety of phthalocyanine derivatives, which are widely utilized in material and life sciences, has been limited by the lack of versatile synthetic methods. Herein we present a synthetic strategy/methodology for the meso-position editing of phthalocyanine derivatives via deprotonative macrocyclization of open-form acyclic phthalonitrile Ni tetramer 1, prepared by thiolate-mediated reductive tetramerization of phthalonitrile and metalation. To illustrate the utility of this protocol, we synthesize several meso-N-edited phthalocyanine derivatives, including 16π-electron antiaromatic tetrabenzodiazanorcorrole 2, and 17π-electron paramagnetic tetrabenzotriazacorrole 3 and tetrabenzodiazacorrole 4. The products are obtained as the nickel(II) complexes. Their unique electronic properties, such as paratropicity and radical character, are characterized both experimentally and computationally. Moreover, antiaromatic compound 2 undergoes further meso-position and skeletal transformations upon reaction with nucleophiles to give nonaromatic and aromatic π-conjugates.

Identifiers

PMID40157916
PMCPMC11954904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.